![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 7, 4782-4789, February 15, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
,
,
,
,
, and

From the The BRG-1 subunit of the SWI·SNF complex is
involved in chromatin remodeling and has been implicated in the action
of the retinoblastoma tumor suppressor (RB). Given the importance of BRG-1 in RB function, germ line BRG-1 mutations in tumorigenesis may be
tantamount to RB inactivation. Therefore, in this study we assessed the
behavior of cells harboring discrete BRG-1 alleles for the RB-signaling
pathway. Using p16ink4a, an upstream activator of endogenous RB, or a
constitutively active RB construct (PSM-RB), we determined that the
majority of tumor lines with germ line defects in BRG-1 were sensitive
to RB-mediated cell cycle arrest. By contrast, A427 (lung carcinoma)
cells were resistant to expression of p16ink4a and PSM-RB. Analysis of
the SWI·SNF subunits in the different tumor lines revealed that A427
are deficient for BRG-1 and its homologue, Brm, whereas RB-sensitive
cell lines retained Brm expression. Similarly, the RB-resistant SW13
and C33A cell lines were also deficient for both BRG-1/Brm.
Reintroduction of either BRG-1 or Brm into A427 or C33A cells restored
RB-mediated signaling to cyclin A to cause cell cycle arrest.
Consistent with this compensatory role, we observed that Brm could also
drive expression of CD44. We also determined that loss of these core SWI·SNF subunits renders SW13 cells resistant to activation of the RB
pathway by the chemotherapeutic agent cisplatin, since reintroduction
of either BRG-1 or Brm into SW13 cells restored the cisplatin
DNA-damage checkpoint. Together, these data demonstrate that Brm can
compensate for BRG-1 loss as pertains to RB sensitivity.
Department of Cell Biology, University of
Cincinnati College of Medicine, Vontz Center for Molecular Studies,
Cincinnati, Ohio 45267-0521, ¶ Department of Pathology and
Laboratory Medicine and
The Lineberger Comprehensive Cancer
Center, University of North Carolina, Chapel Hill, North Carolina
27599, and ** Program in Immunology and Virology, University
of Massachusetts Medical School, Worcester, Massachusetts 01655

To whom correspondence should be addressed: Tel.: 513-558-8885;
Fax: 513-558-4454; E-mail: Erik.Knudsen@UC.edu.
This article has been cited by other articles:
![]() |
C. T. Griffin, J. Brennan, and T. Magnuson The chromatin-remodeling enzyme BRG1 plays an essential role in primitive erythropoiesis and vascular development Development, February 1, 2008; 135(3): 493 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, J. Zhang, and X. Chen The Activity of p53 Is Differentially Regulated by Brm- and Brg1-containing SWI/SNF Chromatin Remodeling Complexes J. Biol. Chem., December 28, 2007; 282(52): 37429 - 37435. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Gunawardena, S. R. Fox, H. Siddiqui, and E. S. Knudsen SWI/SNF Activity Is Required for the Repression of Deoxyribonucleotide Triphosphate Metabolic Enzymes via the Recruitment of mSin3B J. Biol. Chem., July 13, 2007; 282(28): 20116 - 20123. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Eissenberg, M. Wong, and J. C. Chrivia Human SRCAP and Drosophila melanogaster DOM Are Homologs That Function in the Notch Signaling Pathway Mol. Cell. Biol., August 1, 2005; 25(15): 6559 - 6569. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Medina, J. Carretero, E. Ballestar, B. Angulo, F. Lopez-Rios, M. Esteller, and M. Sanchez-Cespedes Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells Hum. Mol. Genet., April 1, 2005; 14(7): 973 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Link, C. J. Burd, E. Williams, T. Marshall, G. Rosson, E. Henry, B. Weissman, and K. E. Knudsen BAF57 Governs Androgen Receptor Action and Androgen-Dependent Proliferation through SWI/SNF Mol. Cell. Biol., March 15, 2005; 25(6): 2200 - 2215. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Wang, R. Zhang, T. V. Beischlag, C. Muchardt, M. Yaniv, and O. Hankinson Roles of Brahma and Brahma/SWI2-Related Gene 1 in Hypoxic Induction of the Erythropoietin Gene J. Biol. Chem., November 5, 2004; 279(45): 46733 - 46741. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Gunawardena, H. Siddiqui, D. A. Solomon, C. N. Mayhew, J. Held, S. P. Angus, and E. S. Knudsen Hierarchical Requirement of SWI/SNF in Retinoblastoma Tumor Suppressor-mediated Repression of Plk1 J. Biol. Chem., July 9, 2004; 279(28): 29278 - 29285. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Muller, C. F. Calkhoven, X. Sha, and A. Leutz The CCAAT Enhancer-binding Protein {alpha} (C/EBP{alpha}) Requires a SWI/SNF Complex for Proliferation Arrest J. Biol. Chem., February 20, 2004; 279(8): 7353 - 7358. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shimono, H. Murakami, K. Kawai, P. A. Wade, K. Shimokata, and M. Takahashi Mi-2{beta} Associates with BRG1 and RET Finger Protein at the Distinct Regions with Transcriptional Activating and Repressing Abilities J. Biol. Chem., December 19, 2003; 278(51): 51638 - 51645. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Angus, D. A. Solomon, L. Kuschel, R. F. Hennigan, and E. S. Knudsen Retinoblastoma Tumor Suppressor: Analyses of Dynamic Behavior in Living Cells Reveal Multiple Modes of Regulation Mol. Cell. Biol., November 15, 2003; 23(22): 8172 - 8188. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Siddiqui, D. A. Solomon, R. W. Gunawardena, Y. Wang, and E. S. Knudsen Histone Deacetylation of RB-Responsive Promoters: Requisite for Specific Gene Repression but Dispensable for Cell Cycle Inhibition Mol. Cell. Biol., November 1, 2003; 23(21): 7719 - 7731. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Marshall, K. A. Link, C. E. Petre-Draviam, and K. E. Knudsen Differential Requirement of SWI/SNF for Androgen Receptor Activity J. Biol. Chem., August 15, 2003; 278(33): 30605 - 30613. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamamichi-Nishina, T. Ito, T. Mizutani, N. Yamamichi, H. Watanabe, and H. Iba SW13 Cells Can Transition between Two Distinct Subtypes by Switching Expression of BRG1 and Brm Genes at the Post-transcriptional Level J. Biol. Chem., February 21, 2003; 278(9): 7422 - 7430. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Reisman, J. Sciarrotta, W. Wang, W. K. Funkhouser, and B. E. Weissman Loss of BRG1/BRM in Human Lung Cancer Cell Lines and Primary Lung Cancers: Correlation with Poor Prognosis Cancer Res., February 1, 2003; 63(3): 560 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Roy, I. L. de la Serna, and A. N. Imbalzano The Myogenic Basic Helix-Loop-Helix Family of Transcription Factors Shows Similar Requirements for SWI/SNF Chromatin Remodeling Enzymes during Muscle Differentiation in Culture J. Biol. Chem., September 6, 2002; 277(37): 33818 - 33824. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Urnov Methylation and the Genome: the Power of a Small Amendment J. Nutr., August 1, 2002; 132(8): 2450S - 2456. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |